Europäische Union - Deutsch - EMA (European Medicines Agency)

lipomed gmbh - thalidomid - multiples myelom - immunsuppressiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Europäische Union - Deutsch - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - thalidomid - multiples myelom - immunsuppressiva - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Schweiz - Deutsch - myHealthbox

bayer ag - difenoconazol; solvent naphtha (petroleum), heavy arom.; kerosine - unspecified; (z)-9-octadecen-1-ol ethoxylated - emulsionskonzentrat (ec) - 23.5 %250 g/l; ; ; - 250 g/l difenoconazol - fungizid ;

Schweiz - Deutsch - OFAG-BLW (Bundesamt für Landwirtschaft)

bayer (schweiz) ag - difenoconazol; solvent naphtha (petroleum), heavy arom.; kerosine - unspecified; (z)-9-octadecen-1-ol ethoxylated - ecemulsionskonzentrat - 23.5 %250 g/l; ; ; - fungizid ;

Europäische Union - Deutsch - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - multiple sklerose, schubförmig-remittierender - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - multiple sklerose, schubförmig-remittierender - immunsuppressiva, selektive immunsuppressiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

biotest pharma gmbh - immunglobulin - immunglobuline, normal

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

biotest pharma gmbh - immunglobulin - varicella/zoster-immung

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

biologische heilmittel heel gmbh - sulfur d10; sulfur d4; vincetoxicum e cinere d30; vincetoxicum hirundinaria d10; vincetoxicum hirundinaria d30; vincetoxicum hirundinaria d6 -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

biologische heilmittel heel gmbh - bryonia d10; bryonia d1000; bryonia d15; bryonia d200; bryonia d30; bryonia d4; bryonia d6; citrullus colocynthis d10; citrullus colocynthis d200; citrullus colocynthis d30; citrullus colocynthis d5; lycopodium clavatum d10; lycopodium clavatum d1000; lycopodium clavatum d200; lycopodium clavatum d30; lycopodium clavatum d5; strychnos nux-vomica d10; strychnos nux-vomica d1000; strychnos nux-vomica d15; strychnos nux-vomica d200; strychnos nux-vomica d30; strychnos nux-vomica d4 -